Clinical trials
Completed Wounds and Injuries trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 7 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 79 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 10 |
| University Hospital, Grenoble | 6 |
| Centre Hospitalier Universitaire de Nīmes | 5 |
| Hospices Civils de Lyon | 4 |
| Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | 3 |
| Central Hospital, Nancy, France | 2 |
| Direction Centrale du Service de Santé des Armées | 2 |
| Nantes University Hospital | 2 |
| Proteor Group | 2 |
| Rennes University Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wounds and Injuries | 79 |
| Disease | 4 |
| Emergencies | 4 |
| Hemorrhage | 4 |
| Pain | 4 |
| Stress Disorders, Post-Traumatic | 4 |
| Anxiety Disorders | 3 |
| Brain Injuries, Traumatic | 3 |
| Hemostatic Disorders | 3 |
| Shock | 3 |
Trials
Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.